Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis
Ephedrine Sulfate injection USP, 50 mg/mL is indicated for the treatment of clinically important hypotension
Phase III ARANOTE trial met primary endpoint, significantly increasing radiological progression-free survival (rPFS) with NUBEQA plus androgen deprivation therapy (ADT) compared to placebo plus ADT
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
The company is planning to expand its plant capacity in in Vapi
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
